Rabanes, Mary Mae O.

HRN: 23-06-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2023
CEFTRIAXONE 1G (VIAL)
05/17/2023
05/23/2023
IV
2g
Q24H
Acute Uncomplicated Pyelonephritis
Waiting Final Action 
05/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/20/2023
05/27/2023
IV
500mg
Q8H
T/c Acute Appendicitis
Waiting Final Action 
05/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/20/2023
05/27/2023
IV
600mg
IV
Empiric
Waiting Final Action 
05/20/2023
FLUCONAZOLE 150MG (CAP)
05/20/2023
05/27/2023
PO
150mg
2x/week
Empiric
Waiting Final Action 
05/20/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
05/20/2023
05/27/2023
PO
30mL
TID
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: